Insider Transactions in Q4 2021 at Surmodics Inc (SRDX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
371
+1.42%
|
$17,808
$48.15 P/Share
|
|
Dec 31
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.23%
|
$18,672
$48.15 P/Share
|
|
Nov 30
2021
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+6.58%
|
-
|
|
Nov 30
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.07%
|
$27,950
$43.93 P/Share
|
|
Nov 30
2021
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,210
+10.29%
|
-
|
|
Nov 30
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,639
-1.84%
|
$113,477
$43.93 P/Share
|
|
Nov 30
2021
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,707
+26.48%
|
-
|
|
Nov 30
2021
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-2.19%
|
$2,924
$43.93 P/Share
|
|
Nov 30
2021
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+9.7%
|
-
|
|
Nov 30
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.69%
|
$27,950
$43.93 P/Share
|
|
Nov 30
2021
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+18.17%
|
-
|
|
Nov 30
2021
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-2.66%
|
$18,748
$43.93 P/Share
|
|
Nov 30
2021
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+8.61%
|
-
|
|
Nov 30
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-1.58%
|
$30,143
$43.93 P/Share
|
|
Nov 30
2021
|
Nusrath Sultana VP, Clinical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
910
+11.09%
|
-
|
|
Nov 30
2021
|
Nusrath Sultana VP, Clinical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-6.33%
|
$18,533
$43.93 P/Share
|
|
Nov 30
2021
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+28.78%
|
-
|
|
Nov 30
2021
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-6.1%
|
$18,748
$43.93 P/Share
|
|
Nov 30
2021
|
Jose H Bedoya |
SELL
Open market or private sale
|
Direct |
5,576
-19.64%
|
$245,344
$44.0 P/Share
|
|
Nov 30
2021
|
Jose H Bedoya |
BUY
Exercise of conversion of derivative security
|
Direct |
5,576
+16.42%
|
$117,096
$21.31 P/Share
|
|
Nov 27
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-0.57%
|
$15,705
$45.77 P/Share
|
|
Nov 27
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-1.02%
|
$66,465
$45.77 P/Share
|
|
Nov 27
2021
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
45
-1.43%
|
$2,025
$45.77 P/Share
|
|
Nov 27
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-0.9%
|
$15,705
$45.77 P/Share
|
|
Nov 27
2021
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.63%
|
$12,195
$45.77 P/Share
|
|
Nov 27
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-0.97%
|
$19,575
$45.77 P/Share
|
|
Nov 25
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-0.88%
|
$25,568
$47.85 P/Share
|
|
Nov 25
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,172
-1.48%
|
$102,084
$47.85 P/Share
|
|
Nov 25
2021
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
61
-1.9%
|
$2,867
$47.85 P/Share
|
|
Nov 25
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-1.2%
|
$22,137
$47.85 P/Share
|
|
Nov 25
2021
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
948
-5.39%
|
$44,556
$47.85 P/Share
|
|
Nov 25
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-1.29%
|
$27,542
$47.85 P/Share
|
|
Nov 24
2021
|
David Dantzker |
SELL
Open market or private sale
|
Direct |
3,475
-10.13%
|
$163,325
$47.01 P/Share
|
|
Nov 03
2021
|
David Dantzker |
SELL
Payment of exercise price or tax liability
|
Direct |
2,101
-5.77%
|
$117,656
$56.56 P/Share
|
|
Nov 03
2021
|
David Dantzker |
BUY
Exercise of conversion of derivative security
|
Direct |
5,576
+13.28%
|
$117,096
$21.31 P/Share
|
|
Nov 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
6,000
-1.97%
|
$324,000
$54.94 P/Share
|
|
Oct 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
6,000
-1.89%
|
$336,000
$56.25 P/Share
|